Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Shareholder Equity 2009–2025
Celldex Therapeutics Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Celldex Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 527.2M, a 29.43% decrease year-over-year.
- Celldex Therapeutics Inc. shareholder equity for 2025 were 527.2M, a 29.43% decrease from 2024.
- Celldex Therapeutics Inc. shareholder equity for 2024 were 747.0M, a 74.06% increase from 2023.
- Celldex Therapeutics Inc. shareholder equity for 2023 were 429.2M, a 31.57% increase from 2022.
- Celldex Therapeutics Inc. shareholder equity for 2022 were 326.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Celldex Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $527 |
| 2024 | $747 |
| 2023 | $429 |
| 2022 | $326 |
| 2021 | $419 |
| 2020 | $209 |
| 2019 | $94 |
| 2018 | $124 |
| 2017 | $236 |
| 2016 | $265 |
| 2015 | $290 |
| 2014 | $212 |
| 2013 | $320 |
| 2012 | $96 |
| 2011 | $69 |
| Celldex Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $527 |
| 2024-12-31 | $747 |
| 2023-12-31 | $429 |
| 2022-12-31 | $326 |
| 2021-12-31 | $419 |
| 2020-12-31 | $209 |
| 2019-12-31 | $94 |
| 2018-12-31 | $124 |
| 2017-12-31 | $236 |
| 2016-12-31 | $265 |
| 2015-12-31 | $290 |
| 2014-12-31 | $212 |
| 2013-12-31 | $320 |
| 2012-12-31 | $96 |
| 2011-12-31 | $69 |
| 2010-12-31 | $75 |
Celldex Therapeutics Inc. Shareholder Equity — FAQ
Celldex Therapeutics Inc. (CLDX) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's shareholder equity history?
The chart and table above show Celldex Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.